Hunan Warrant Pharmaceutical Co (SHSE:688799) Change In Receivables: ¥ Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688799 Hunan Warrant Pharmaceutical Co Ltd SHSE:688799
79 GF Score
Price ¥59.31
GF Value ¥35.00
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hunan Warrant Pharmaceutical Co Change In Receivables?

Hunan Warrant Pharmaceutical Co SHSE:688799 +5.72% 79 Change In Receivables is ¥ Mil as of Jun. 2026. GuruFocus rates SHSE:688799 with a GF Score™ of 79/100 and a GF Value™ of ¥35.00 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Hunan Warrant Pharmaceutical Co's change in receivables for the quarter that ended in Jun. 2026 was ¥ Mil. It means Hunan Warrant Pharmaceutical Co's Accounts Receivable stayed the same from Mar. 2026 to Jun. 2026 .

Hunan Warrant Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2025 was ¥ Mil. It means Hunan Warrant Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2024 to Dec. 2025 .

Hunan Warrant Pharmaceutical Co's Accounts Receivable for the quarter that ended in Jun. 2026 was ¥266 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hunan Warrant Pharmaceutical Co's Days Sales Outstanding for the three months ended in Jun. 2026 was 72.13.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hunan Warrant Pharmaceutical Co's liquidation value for the three months ended in Jun. 2026 was ¥-635 Mil.

Hunan Warrant Pharmaceutical Co  (SHSE:688799) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hunan Warrant Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=265.69718414/336.14525212*91
=72.13

2. In Ben Graham's calculation of liquidation value, Hunan Warrant Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Hunan Warrant Pharmaceutical Co's liquidation value for the quarter that ended in Jun. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=288.51041085-1316.51272419+0.75 * 265.69718414+0.5 * 387.74251158
=-635

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Warrant Pharmaceutical Co Change In Receivables Related Terms

Hunan Warrant Pharmaceutical Co Change In Receivables Historical Data

* Premium members only.

The historical data trend for Hunan Warrant Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Warrant Pharmaceutical Co Change In Receivables Chart

Hunan Warrant Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial - - - - -

Hunan Warrant Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
SHSE:688799
79GF Score
Hunan Warrant Pharmaceutical Co Ltd SHSE:688799
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hunan Warrant Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of ¥ Mil mean?
Hunan Warrant Pharmaceutical Co (SHSE:688799) has a Change In Receivables of ¥ Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hunan Warrant Pharmaceutical Co and its competitors.
Is Hunan Warrant Pharmaceutical Co's Change In Receivables too high?
Hunan Warrant Pharmaceutical Co's current Change In Receivables is ¥ Mil. Overall, Hunan Warrant Pharmaceutical Co has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Warrant Pharmaceutical Co's Change In Receivables compare to ZTS?
Hunan Warrant Pharmaceutical Co's Change In Receivables of ¥ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Hunan Warrant Pharmaceutical Co and its competitors. Hunan Warrant Pharmaceutical Co's current Change In Receivables is ¥ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Warrant Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Warrant Pharmaceutical Co (SHSE:688799) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥35.00, compared to a current price of ¥59.31 — trading 69.5% above its estimated fair value. The current Change In Receivables is ¥ Mil. Hunan Warrant Pharmaceutical Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Hunan Warrant Pharmaceutical Co (SHSE:688799), the current Change In Receivables is ¥ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hunan Warrant Pharmaceutical Co (SHSE:688799) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Warrant Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥59.31 is trading 69.5% above its estimated GF Value™ of ¥35.00. GuruFocus considers Hunan Warrant Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688799:

  • Change In Receivables: ¥ Mil
  • GF Value™: ¥35.00 vs. price of ¥59.31 (69.5% above fair value)
  • GF Score™: 79/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688799 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hunan Warrant Pharmaceutical Co Business Description

Address No. 28 Lutian Road, Building C6-C7, Yuelu District, Changsha, CHN, 410006
Hunan Warrant Pharmaceutical Co Ltd is a pharmaceutical manufacturer. It is engaged in the research and development, production and sales of chemical raw materials, chemical medicine preparations and Chinese medicine preparations.
79GF Score

Get the complete analysis for SHSE:688799

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥59.31
Price
¥35.00
GF Value